NCT06891040

Phase II Clinical Study to Evaluate the Efficacy and Safety of VC005 in Adult Subjects With Mild to Moderate Atopic Dermatitis

A Multicenter, Randomized, Double-blind, Vehicle Controlled Phase II Clinical Study to Evaluate the Efficacy and Safety of VC005 in Adult Subjects With Mild to Moderate Atopic Dermatitis

• Status: Completed
• Phase: Phase 2
• Study type: Interventional
• Enrollment: 118 (actual)
• Sponsor: Jiangsu vcare pharmaceutical technology co., LTD · Industry
• Sex: All
• Age: 18 Years
• Healthy volunteers: Not accepted

Summary

A multicenter, randomized, double-blind, vehicle controlled phase II clinical study

Conditions

• Atopic Dermatitis

Interventions

Type	Name	Description
DRUG	VC005 Placebo group	VC005 Placebo group with Local topical application
DRUG	VC005 groups	VC005 group with Local topical application

Timeline

• Start date: 2025-04-28
• Primary completion: 2025-10-31
• Completion: 2025-11-04
• First posted: 2025-03-24
• Last updated: 2026-04-13

Locations

1 site across 1 country: China